Sort
39,280 grants matching “leukemia”
Roles of CBP &PCAF During Hematopoietic Differentiation
$299,200Childrens Hospital Of Philadelphia · R01 · FY2005 · DK
Roles of CBP &PCAF During Hematopoietic Differentiation
$299,200Childrens Hospital Of Philadelphia · R01 · FY2004 · DK
Roles of CBP &PCAF During Hematopoietic Differentiation
$299,200Children'S Hospital Of Philadelphia · R01 · FY2003 · DK
Regulation of adult progenitor cells and neural repair
$299,167Philip J Horner · University Of Washington · R01 · FY2007 · NS
Regulation of adult progenitor cells and neural repair
$299,167Philip J Horner · University Of Washington · R01 · FY2008 · NS
Mechanisms of Chronic Myeloid Leukemia Progenitor Cell Survival
$299,139Michael W Deininger · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Cancer Center Support Grant (CCSG)
$299,112George J Weiner · University Of Iowa · P30 · FY2020 · CA
Program 1: Cancer Genes and Pathways
$299,112Dawn E Quelle · University Of Iowa · P30 · FY2020 · CA
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
$299,106Ameeta Kelekar · University Of Minnesota · R01 · FY2011 · CA
EVALUATION OF GENETIC THERAPY IN FANC MICE
$299,094Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2004 · HL
Cancer Chemical and Structural Biology
$299,086James M Berger · Johns Hopkins University · P30 · FY2025 · CA
Hematologic Malignancies and Bone Marrow Transplantation
$299,086Richard J Jones · Johns Hopkins University · P30 · FY2025 · CA
Pharmacogenetics of Ara-C Metabolic Pathway
$299,001Jatinder K. Lamba · University Of Minnesota · R01 · FY2009 · CA
MOLECULAR ANALYSIS OF FANCONI'S ANEMIA C PROTEIN
$299,000Baylor College Of Medicine · R01 · FY2001 · HL
MOLECULAR ANALYSIS OF FANCONI'S ANEMIA C PROTEIN
$299,000Baylor College Of Medicine · R01 · FY2000 · HL
MOLECULAR ANALYSIS OF FANCONI'S ANEMIA C PROTEIN
$299,000Baylor College Of Medicine · R01 · FY2003 · HL
MOLECULAR ANALYSIS OF FANCONI'S ANEMIA C PROTEIN
$299,000Baylor College Of Medicine · R01 · FY2002 · HL
Bispecific Antibody Engineering for AML RIT
$298,976Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
REGULATION OF MYELOPOIESIS
$298,972Dana-Farber Cancer Institute · R37 · FY2002 · CA
Resistance of CML stem cells to STI571 (Gleevec)
$298,965Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA
Next-generation precision medicine for targeting recombination-deficient cancers
$298,959Richard T Pomerantz · Recombination Therapeutics, Llc · R41 · FY2020 · CA
Dendritic cell therapy for GvHD
$298,956Katherine L Knight · Hasentech, Inc. · R41 · FY2025 · AI
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
$298,935Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia
$298,928Ping Cao · Bridgene Biosciences, Inc. · R41 · FY2020 · CA
The switch between epigenetically silenced and active chromatin states
$298,906Vincenzo Pirrotta · Rutgers, The State Univ Of N.J. · R01 · FY2012 · GM